Adenovir Pharma AB   Report issue

For profit Phase 2
Founded: Helingsborg Sweden (2008)
Status: Defunct (2019)

Organization Overview

First Clinical Trial
2013
NCT01977443
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (1)

megestrol (megace) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Conjunctivitis (Phase 2)

Conjunctivitis, Viral (Phase 2)

Keratoconjunctivitis (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1